Alpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?

Few longevity supplements have a marketing number as sticky as alpha-ketoglutarate's. The pitch — that taking AKG (sold most prominently as Rejuvant) made people roughly eight years biologically younger — spread across podcasts and supplement stores as if it were a settled scientific result. It is not. Behind that headline is a single small study with a design that can't support a causal claim, conducted with manufacturer involvement, using a biological-age "clock" that isn't validated for proving an individual got younger. This page walks through what AKG actually is, what the famous study really showed, and why the gap between the marketing and the evidence is so wide. For the wider map of what's earned its place versus what's hype, start with our pillar on longevity medicine: what's proven vs hyped.

What AKG is

Alpha-ketoglutarate (AKG, also written α-KG or 2-oxoglutarate) is not an exotic drug — it's an endogenous metabolite, a central intermediate in the Krebs cycle that every cell uses to make energy. It also sits at the crossroads of several processes biologists care about in aging: it's a co-substrate for enzymes that regulate DNA and histone methylation (so it can influence epigenetics), it feeds amino-acid and collagen synthesis, and it participates in nutrient-sensing pathways⁴. Levels of circulating AKG fall with age, which is the mechanistic seed of the whole longevity pitch. The consumer products are usually a calcium salt (calcium-AKG, the form in Rejuvant), sometimes combined with small amounts of vitamins. So far, so plausible — AKG touches real aging biology. The question, as always on this site, is whether swallowing it does anything measurable for a person.

The mouse data: a genuine result, but in mice

AKG's serious scientific credibility comes from animal work. In a 2020 study, calcium-AKG given to aging mice extended lifespan and, more strikingly, compressed morbidity — the animals didn't just live a bit longer, they spent a larger fraction of their remaining life healthy, with the effect partly attributed to AKG-driven changes in inflammation². That "compression of morbidity" framing is genuinely appealing: the goal of longevity medicine isn't just more years but more healthy years. Reviews of the broader literature catalogue consistent lifespan- and healthspan-extending signals for AKG across model organisms³.

This is a real, respectable preclinical package — better than many supplements can claim. But it carries the caveat that haunts this entire field: a metabolite that extends lifespan in mice is a hypothesis about humans, not a result in them. Rodent lifespan extensions translate to people far less often than headlines imply, and AKG has no human lifespan or hard-outcome trial at all.

The "8 years younger" study: what it actually was

The human claim everyone repeats comes from a single 2021 paper in Aging (Albany NY) by Demidenko and colleagues, reporting on Rejuvant (a calcium-AKG formulation)¹. Here is what it genuinely was — and why each feature matters:

It was small: about 42 people. That's a pilot-scale sample, fine for generating a hypothesis, far too small and selective to establish a population effect.

It had no placebo or control group. This is the decisive flaw. The study looked at participants' biological-age readings before and after taking the product — but with nobody taking a dummy product for comparison, there is no way to know whether any change was caused by AKG, by regression to the mean, by lifestyle changes in motivated supplement-takers, or by the measurement's own noise. A before-after change in an uncontrolled group is the weakest common design in clinical research, and it cannot support a causal "made people younger" claim.

The "younger" number came from an unvalidated aging clock. The biological-age reduction (the ~8-year figure widely quoted) was measured with a DNA-methylation "clock." As we explain in detail in our review of biological age tests, these epigenetic clocks predict aging across large populations but are noisy and not validated for telling an individual whether an intervention actually slowed their aging. Using such a clock as the primary endpoint, without a control arm, stacks an unproven measurement on top of an uncontrolled design.

There was manufacturer involvement. The study was connected to the company commercializing the product — a standard conflict-of-interest flag. It doesn't automatically make the data wrong, but industry-run studies of a company's own product, especially small uncontrolled ones, warrant extra skepticism and independent replication before the result is trusted.

Put those together and the honest summary is stark: the famous "8 years younger" figure rests on a ~42-person, placebo-free, manufacturer-linked study measured with a clock that can't validly prove individual rejuvenation. That is a weak study, not a breakthrough.

Supplement status and safety

AKG is sold as a dietary supplement, not an FDA-approved drug for aging or any condition — no approved indication, no required efficacy proof, label content the manufacturer controls. On safety, the reassuring side is that AKG is an endogenous metabolite the body already makes and uses, calcium-AKG has been used without notable safety alarms in the small human study¹, and reviews of human AKG use describe it as generally well tolerated³. But "appears tolerable in a tiny short study" is not the same as "proven safe for years of self-directed use," and the calcium content of calcium-AKG is worth accounting for if you already supplement calcium. The honest framing is the one this site uses throughout: AKG's mechanism and mouse data are interesting, its safety at studied doses looks reasonable, and its human longevity efficacy is unproven — three separate claims the marketing collapses into one. We apply the same lens across the field in our best longevity supplements, rated by evidence roundup, and the same skepticism toward biological-age marketing in our longevity clinic cost breakdown of what these programs actually charge for unproven metrics.

The grade

The bottom line

Alpha-ketoglutarate has a better scientific foundation than the average supplement: it's a real metabolite that touches aging biology, and the 2020 mouse study showing extended lifespan with compressed morbidity is a genuinely interesting result. But the human story that made AKG famous — "8 years younger" — is built on a single ~42-person study with no placebo group, manufacturer involvement, and an unvalidated epigenetic clock as its yardstick. That design cannot establish that AKG makes humans biologically younger; it can only generate a hypothesis worth testing properly. Until a larger, controlled, independent trial measures hard outcomes, AKG sits where most of this field does: promising biology, unproven in people, and badly oversold by a number that sounds far more solid than the study behind it. If you take AKG, take it knowing the safety looks reasonable and the rejuvenation claim is not earned. For where supplements like this fit alongside programs with real clinical oversight, see our graded best longevity clinics hub.